Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (92 total)
-
Créateur: United Kingdom Department of Health (DH)
Sujet: Research
Type d'élément: Guide
Date de la dernière mise à jour: 2019-07-19
Description: This report summarizes the establishment of the Ebola Biobank, its governance, and how materials were safely transported in 2015 from West Africa to the United Kingdom for curation by Public Health England. The Biobank is a secure but accessible… -
Créateur: the mRNA-1273 Study Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2020-07-14
Description: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine mRNA-1273 encodes the stabilized prefusion… -
Créateur: the mRNA-1273 Study Group
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-06
Description: Interim results from a phase 3 trial of the Moderna mRNA-1273 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine indicated 94% efficacy in preventing coronavirus disease 2019 (Covid-19). -
Créateur: Manisty, Charlotte, Ashley D. Otter, Thomas A. Treibel, Áine McKnight, Daniel M. Altmann, Timothy Brooks, Mahdad Noursadeghi, Rosemary J. Boyton, Amanda Semper, and James C. Moon.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-02-25
Description: Rapid vaccine-induced population immunity is a key global strategy to control COVID-19. Vaccination programmes must maximise early impact, particularly with accelerated spread of new variants. -
Créateur: Li, L., L. B. Robinson, R. Patel, A. B. Landman, X. Fu, E. S. Shenoy, D. M. Hashimoto, A. Banerji, P. G. Wickner, U. Samarakoon, C. M. Mancini, Y. Zhang, and K. G. Blumenthal.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-10-01
Description: Allergic history in individuals with confirmed anaphylaxis to a messenger RNA (mRNA) COVID-19 vaccine is common. However, the risk factors for allergy symptoms after receiving the vaccine are unknown. -
Créateur: Bayas, Antonios, Martina Menacher, Monika Christ, Lars Behrens, Andreas Rank, and Markus Naumann.
Sujet: Treatment & Care
Type d'élément: Publication
Date de la dernière mise à jour: 2021-04-14
Description: Clinical Picture of Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination in a 55-year-old woman -
Créateur: Benenson, Shmuel, Yonatan Oster, Matan J. Cohen, and Ran Nir-Paz.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2021-03-23
Description: The surge of coronavirus disease 2019 (Covid-19) around the world and the need for urgent and intensive medical care have weighed heavily on health care systems and hospitals.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Créateur: National Academies of Sciences, E. and Medicine
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2017-10-31
Description: During public health emergencies (PHEs) involving chemical, biological, radiological, or nuclear threats or emerging infectious diseases, medical countermeasures (MCMs) (e.g., drugs, vaccines, devices) may need to be dispensed or administered to…